GeneDx Holdings Corp [WGS] stock prices are up 3.50% to $109.39 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The WGS shares have gain 11.30% over the last week, with a monthly amount glided 8.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $34. Previously, Craig Hallum started tracking the stock with Buy rating on July 10, 2024, and set its price target to $43.
The stock price of GeneDx Holdings Corp [WGS] has been fluctuating between $10.70 and $115.60 over the past year. Currently, Wall Street analysts expect the stock to reach $42.5 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $109.39 at the most recent close of the market. An investor can expect a potential drop of -61.15% based on the average WGS price forecast.
Analyzing the WGS fundamentals
The GeneDx Holdings Corp [NASDAQ:WGS] reported sales of 305.45M for trailing twelve months, representing a surge of 66.57%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.25 and Total Capital is -0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 106.40 points at the first support level, and at 103.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 111.12, and for the 2nd resistance point, it is at 112.86.
Ratios To Look Out For
It’s worth pointing out that GeneDx Holdings Corp [NASDAQ:WGS]’s Current Ratio is 3.61. Further, the Quick Ratio stands at 3.42, while the Cash Ratio is 1.55. Considering the valuation of this stock, the price to sales ratio is 10.22, the price to book ratio is 12.50.
Transactions by insiders
Recent insider trading involved ICAHN SCHOOL OF MEDICINE AT MO, Stockholder, that happened on Apr 14 ’25 when 0.25 million shares were purchased. CHIEF FINANCIAL OFFICER, Feeley Kevin completed a deal on Apr 09 ’25 to sell 15516.0 shares. Meanwhile, Chief Executive Officer Stueland Katherine sold 46594.0 shares on Apr 09 ’25.
